Riskpilot← Back to searchSign inGet full accessHAMEC AS
ASActiveOrg 988989029Kjøvangveien 17A, 1553 SonTraditional, complementary and alternative medicine activities · NACE 8696Est. 20060 employees
Revenue 2024
NOK 696K
+255% vs 2023
EBITDA margin
49.1%
+126% vs 2023
Equity ratio
92.1%
Financial strength
Net profit 2024
NOK 1,3M
-92% vs 2023
| Revenue | NOK 696K | +255% |
| EBITDA | NOK 342K | +126% |
| Net profit | NOK 1,3M | -92% |
| Total assets | NOK 118,6M | -1% |
| Equity | NOK 109,2M | -6% |
| Employees | 0 | — |
Legal name
HAMEC AS
Org number
988989029
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
17. januar 2006
Share capital
NOK 1 680 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investering i eiendom og finansaktiva, inkludert aksjer i andre selskaper og alt som naturlig faller inn under dette.
Address
Kjøvangveien 17A, 1553 Son
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 900 | 33 | 49 | 196 | 696 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 8 851 | −97 | −257 | −1 302 | 342 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 8 851 | −97 | −257 | −1 302 | 342 |
| Net financials | 13 | −290 | 92 880 | 16 647 | 1 053 |
| Profit before tax | 8 864 | −387 | 92 623 | 15 346 | 1 395 |
| Tax | −0 | −0 | 60 | −0 | 119 |
| Net profit | 8 864 | −387 | 92 563 | 15 346 | 1 276 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 26 031 | 21 579 | 109 559 | 119 361 | 118 594 |
| Equity | 16 761 | 14 375 | 109 042 | 115 929 | 109 205 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 9 270 | 7 204 | 517 | 3 432 | 9 389 |
| Total debt | 9 270 | 7 204 | 517 | 3 432 | 9 389 |
EBITDA margin
49.1%
This company
15.8%
Market median
+211% vs market
20202024
Equity ratio
92.1%
This company
38.2%
Market median
+141% vs market
20202024
Return on equity
1.2%
This company
18.4%
Market median
-93% vs market
20202024
Net profit margin
183.2%
This company
8.1%
Market median
+2162% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2006 | |
| Board of Directors | 2006 | |
| Board of Directors | 2006 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 24.89% | 24.89% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HAMEC AS 
ASAMEDIC ASBoard members of HAMEC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maren Helly-Hansen Sørbye | Board of Directors | 0 companies |
| Camilla Sørbye | Board of Directors | 0 companies |
| Even Helly-Hansen Sørbye | Board of Directors | 0 companies |